JPY 2115.0
(0.14%)
Breakdown | 2022 | 2021 | 2020 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 19.99 Billion | 11.37 Billion | 4.75 Billion | 29.68 Billion | -28.02 Billion | -5.63 Billion |
Net Income | 4.61 Billion | 4.92 Billion | 3.26 Billion | 4.62 Billion | 3.83 Billion | 2.97 Billion |
Depreciation & Amortization | 148 Million | 148 Million | 95.99 Million | 116.1 Million | 166.16 Million | 159.51 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 12.79 Billion | 5.74 Billion | 3.36 Billion | 26.2 Billion | -30.97 Billion | -8.32 Billion |
Other non-cash items | 2.43 Billion | 554 Million | -1.97 Billion | -1.27 Billion | -1.04 Billion | -446.75 Million |
Investing Cash Flow | -156 Million | -17.51 Billion | -130.66 Million | 1.16 Billion | -7.14 Million | 154.42 Million |
Investments in PPE | -379 Million | -13.37 Billion | -73.33 Million | -144.13 Million | -323.7 Million | -37.75 Million |
Acquisitions | 371 Million | -3.43 Billion | - | - | 171.41 Million | - |
Investment purchases | -297 Million | -559 Million | - | - | - | - |
Sales/Maturities of investments | 348 Million | - | - | 1.31 Billion | 415.93 Million | - |
Other Investing Activities | -199 Million | -148 Million | -57.33 Million | -15.07 Million | -270.78 Million | 192.17 Million |
Financing Cash Flow | -13.97 Billion | 2.36 Billion | -5.92 Billion | -27.82 Billion | 32.51 Billion | 6.41 Billion |
Debt repayment | -43.29 Billion | -35.07 Billion | -59.72 Billion | -59.72 Billion | -29.95 Billion | -21.45 Billion |
Dividends payments | -913 Million | -458 Million | -1.33 Billion | -992.03 Million | -982.1 Million | -981.91 Million |
Common Stock Repurchased | - | - | - | - | 63.24 Billion | 28.97 Billion |
Common Stock Issuance | - | - | - | 289.75 Million | 204.45 Million | 2.82 Million |
Other Financing Activities | 30.22 Billion | 37.89 Billion | 55.13 Billion | 32.6 Billion | -2000.00 | -126.16 Million |
Accounts receivables | - | - | -67.99 Million | - | 81 Million | - |
Accounts payables | - | - | - | - | - | - |
Inventory | 13.44 Billion | 5.36 Billion | 3.43 Billion | 25.94 Billion | -28.83 Billion | -9.54 Billion |
Other working capital | -648 Million | 380 Million | - | 260.86 Million | -2.22 Billion | 1.22 Billion |
Cash at beginning of period | 17.17 Billion | 20.89 Billion | - | 18.85 Billion | 14.5 Billion | 13.57 Billion |
Cash at end of period | 23.14 Billion | 17.17 Billion | -1.27 Billion | 21.85 Billion | 18.85 Billion | 14.5 Billion |
Capital Expenditure | -379 Million | -13.37 Billion | -73.33 Million | -144.13 Million | -323.7 Million | -37.75 Million |
Effect of forex changes on cash | 99 Million | 57 Million | 22.66 Million | -27.7 Million | -135.8 Million | 7.2 Million |
Net cash flow / Change in cash | 5.96 Billion | -3.71 Billion | -1.27 Billion | 2.99 Billion | 4.34 Billion | 934.28 Million |
Free Cash Flow | 19.61 Billion | -2 Billion | 4.68 Billion | 29.53 Billion | -28.34 Billion | -5.67 Billion |
Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -157 Million | 1.35 Billion | 2.29 Billion | 4.61 Billion | -1.22 Billion | 483 Million |
Depreciation & Amortization | - | - | - | 148 Million | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | 12.79 Billion | - | - |
Other non-cash items | 157 Million | -1.35 Billion | -2.29 Billion | 2.43 Billion | 1.22 Billion | -483 Million |
Investing Cash Flow | - | - | - | -156 Million | - | - |
Investments in PPE | - | - | - | -379 Million | - | - |
Acquisitions | - | - | - | 371 Million | - | - |
Investment purchases | - | - | - | -297 Million | - | - |
Sales/Maturities of investments | - | - | - | 348 Million | - | - |
Other Investing Activities | - | - | - | -199 Million | - | - |
Financing Cash Flow | - | - | - | -13.97 Billion | - | - |
Debt repayment | - | - | - | -43.29 Billion | - | - |
Dividends payments | - | - | - | -913 Million | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | 30.22 Billion | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | 13.44 Billion | - | - |
Other working capital | - | - | - | -648 Million | - | - |
Cash at beginning of period | - | - | - | 17.17 Billion | - | - |
Cash at end of period | - | - | - | 23.14 Billion | - | - |
Capital Expenditure | - | - | - | -379 Million | - | - |
Effect of forex changes on cash | - | - | - | 99 Million | - | - |
Net cash flow / Change in cash | - | - | - | 5.96 Billion | - | - |
Free Cash Flow | - | - | - | 19.61 Billion | - | - |
ARGTF
MAZDOCK
SURANASOL
GEBHY
3769
PSB